China Weight-Loss Drug Stocks Lose Shine on ‘Misleading’ Claims

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 50%

Business News News

Business Business Latest News,Business Business Headlines

One of the few bright spots in China’s battered equity market is evaporating, with weight-loss drugs plunging after a company apologized for earlier misleading investors on such treatments.

Apple’s Cook Cheers on Tencent Game Gala in Surprise China VisitAsia Stocks to Rise on Mideast Diplomacy Efforts: Markets WrapSaudi Savola Weighs $5.4 Billion Almarai Stake SaleSouth Africa Set to Topple Nigeria to Regain Mantle as Continent’s Biggest EconomyTSMC Drops Plan for Chip Plant After Reports of Local ProtestsLabour Investment Plans Could Deliver ‘Meaningful’ Boost for UKRBA Staff Consider Strike After Pay Talks Turn Sour, Union SaysSaudi Savola Weighs $5.

5B this year: PBOPharmacare would cost public sector billions more a year, but save economy money: PBOCanadians are cutting back on spending, RBC report showsRoyal LePage downgrades Q4 housing price forecast; expecting 7% increaseDurable goods to blame for inflation burst, no need for rate hike: reportBRI Latest: Forum for Xi’s Signature Project Starts in BeijingWhiskey Giant Chivas Looks to Push More Single Malts Into IndiaSpaceX Fights to Extend Ban on Regulating Commercial...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in BUSİNESS

Business Business Latest News, Business Business Headlines